Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC): RADIANT trial.
- Authors
- O'Brien, Mary E. R.; Eberhardt, Wilfried Ernst Erich; Altorki, Nasser K.; Spigel, David R.; Crino, Lucio; Tsai, Chun-Ming; Cho, Eun Kyung; Kim, Joo-Hang; Szczesna, Aleksandra; Hoffman, Philip C.; Burghuber, Otto; Keshavjee, Shaf; Orlov, Sergey; Serwatowski, Piotr; Wang, Jiuzhou; Foley, Margaret A.; Horan, Julie D.; Park, Jung Wook; Shepherd, Frances A.; Kelly, Karen
- Issue Date
- 20-May-2014
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.32, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 32
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)